Cimicifuga Extract for Type 2 Diabetes via AMPK Activation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current Cimicifuga plant products do not effectively lower blood glucose levels, which is a requirement for treating diabetes mellitus type 2, and their use in diabetes treatment is not established as a recognized medical indication.

Innovation Solution

An extract from Cimicifuga racemosa, preferably prepared with an organic polymer like polyvinylpyrrolidone, is used for the therapeutic or prophylactic treatment of diabetes mellitus type 2 and as an adjuvant treatment for insulin-dependent type 1 diabetes, administered orally or through other routes, to improve metabolic control and glucose homeostasis.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If Cimicifuga plant products are used for diabetes treatment, then metabolic control is improved, but blood glucose lowering effect is insufficient

Engineering Contradiction:
Improvemetabolic controlVSAvoidblood glucose levels
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent applies parameter changes by modifying the extraction parameters and composition of Cimicifuga plant products to enhance their blood glucose lowering effect. The extract is prepared with specific parameters (extraction solvent, temperature, time) to optimize the concentration of active ingredients that can effectively lower blood glucose while maintaining metabolic control improvement.

Inventive Principle:
Principle #35Parameter changes

2Productivity

If Cimicifuga extract is prepared with organic polymer, then extraction efficiency is improved, but product complexity increases

Engineering Contradiction:
Improveextraction efficiencyVSAvoidproduct complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent uses organic polymers as intermediaries in the extraction process. The polymer acts as a mediator that enhances the extraction of active ingredients from Cimicifuga plant material by improving solubility and extraction efficiency. The polymer is used in controlled amounts and can be removed or remains as an inert component in the final extract, thus improving productivity while managing complexity.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Ease of operation

If Cimicifuga extract is administered orally, then ease of administration is improved, but bioavailability may be reduced

Engineering Contradiction:
Improveease of administrationVSAvoidbioavailability
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The organic polymer in the extract serves as an intermediary that improves the bioavailability of active ingredients during oral administration. The polymer protects the active compounds from degradation in the gastrointestinal tract and enhances their absorption, thus maintaining ease of oral administration while improving reliability of bioavailability.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent optimizes parameters of the extract preparation to enhance oral bioavailability. This includes adjusting the extraction solvent composition, pH, and concentration of active ingredients to ensure stability and absorption efficiency in the oral route, thereby maintaining ease of administration while improving bioavailability reliability.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The Cimicifuga extract demonstrates dose-dependent activation of AMPK, leading to improved metabolic control, reduced body weight, decreased food and water intake, and enhanced insulin sensitivity, effectively managing blood glucose levels and preventing diabetes progression.

Implementation Method 1

The Cimicifuga extract demonstrates dose-dependent activation of AMPK

Methodology Applied
Scientific EffectAMPK activation:

Data Source

PatentUS11541093B2Pharmacological use of <i>Cimicifuga </i>extract
Publication Date: 2023.01.03 MAX ZELLER & SOEHNE AG
  • US11541093B2 patent drawing
  • US11541093B2 patent drawing
  • US11541093B2 patent drawing

AI summary

The present invention relates to the novel use of an extract from a Cimicifuga species, preferably Cimicifuga racemosa (also termed Actaea racemosa L; black cohosh). In particular, the invention is directed to an extract from Cimicifuga sp., preferably Cimicifuga racemosa, for use in the therapeutic or prophylactic treatment of diabetes, preferably diabetes mellitus type 2, the use of such extracts for preparing a medicament, corresponding pharmaceutical compositions comprising the extract as well as a method for the therapeutic or prophylactic treatment of diabetes, preferably by oral administration of the extract or pharmaceutical composition.